Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
gene editing
life sciences
2
×
national blog main
allergan
boston
boston blog main
boston top stories
clinical study
clinical trials
crispr
cynthia collins
data
disease
drugs
editas medicine
enzyme
gag
genome editing
hunter syndrome
ids
katrine bosley
leber congenital amaurosis
mps ii
mucopolysaccharidosis ii
national top stories
san francisco
san francisco blog main
san francisco top stories
sandy macrae
sangamo therapeutics
studies
zinc finger nucleases
What
editing
gene
humans
2
×
medicine
trial
2
×
allergan
benefit
blessing
bosley
ceo
check
clinical
crispr
cusp
depart
editas
experimental
going
isn't
katrine
landmark
little
million
morning
nasdaq
partner
phase
regulatory
reported
reports
results
sangamo
study
test
therapeutics
therapy
u.s
Language
Current search:
humans
×
trial
×
" life sciences "
×
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
